Advanced Search

 

Study ID Status Title Patient Level Data
SFCB3023 Completed A multicentre, randomised, double-blind, double-dummy, parallel-group, three-month comparison of the salmeterol/fluticasone propionate combination product (2x25/250mcg strength) bd via the pressurised metered dose inhaler with salmeterol/fluticasone propionate combination product (1x50/500mcg st ...
SFCB3024 Completed A multicentre, randomised, double-blind, parallel group study to compare the efficacy and safety of the Salmeterol/Fluticasone combination product (50/500mg strength) twice daily with Salmeterol 50mg twice daily alone and Fluticasone Propionate 500mg twice daily alone, all delivered via the Diskus/Accuhaler inhaler, in the treatment of patients with chronic obstructive pulmonary disease. Study Listed on ClinicalStudyDataRequest.com
SFCF4001 Completed Uncontrolled asthma in adults: comparison of combination FP/salmeterol (administered via Diskus) with doubling the dosage of inhaled corticosteroid + long acting ?2-mimetic or adding long acting ?2-mimetic to corticosteroid previously inhaled.
SFCF4002 Completed Asthma controlled by Seretide in adults with persistent moderate asthma : efficacy in preventing exacerbations and quality of life
SFCF4006 Completed Study of control of moderate to severe asthma with Seretide in general practice.
SFCF4007 Completed Comparison of the efficacy and safety of Seretide and beclomethasone dipropionate plus montelukast in asthma.
SFCF4020 Completed Asthma control: evaluation in adults during treatment with Seretide
SFCF4021 Completed Research of predictive factors for the response to Seretide® in chronic obstructive pulmonary disease patients with FEV1<50%
SIG102335 Completed Double-blind, placebo-controlled, 3-way crossover study to investigate the effect of 7-days repeat once daily inhaled doses of GW870086X administered via DISKHALER on airway responsiveness to AMP in mild steroid-naive male asthmatics
SIG103337 Completed A randomised, double-blind, placebo-controlled, incomplete block, 4-period crossover, study to investigate the effects of 5-day repeat inhaled doses of fluticasone propionate (BID, 50-2000 mcg) on airway responsiveness to adenosine 5-monophosphate (AMP) challenge when delivered after the last dose in mild asthmatic subjects. Study Listed on ClinicalStudyDataRequest.com
SK&F-105517/321 Completed A multicenter, placebo-controlled, 8-month study of the effect of twice daily carvedilol in children withcongestive heart failure due to systemic ventricular systolic dysfunction
SKF104864/722 Completed A Phase I Study of Oral Topotecan in Subjects with Cancer and Impaired Renal Function
SLG102 Completed A Double-Blind Evaluation of Efficacy, Safety, and Tolerability of Several Single Doses of Salmeterol Hydroxynaphthaote (GR33343G) Compared With Albuterol and Placebo in Asthmatic Patients
SLGA2002 Completed A randomized, double-blind, double-dummy, single-dose, three-way cross-over comparison of salmeterol xinafoate 50mcg and placebo given by the multi-dose powder inhaler and Diskhaler for the prevention of exercise-induced bronchospasm in adolescent and adult patients with asthma.
SLGA2004 Completed A randomized, double-blind, double-dummy, placebo-controlled, comparative clinical trial of salmeterol xinafoate via multi-dose powder inhaler versus salmeterol xinofoate via Diskhaler for four weeks in adolescent and adult subjects with mild-to-moderate asthma.
SLGA2014 Completed A randomized, double-blind, double-dummy, single-dose, four-way cross-over comparison of salmeterol 25mcg and 50mcg given by the multi-dose powder inhaler (DISKUSTM), albuterol 180mcg given by the metered-dose inhaler, and placebo for the prevention of exercise-induced bronchospasm in pediatric ...
SLGA2015 Completed A Randomized, Double-Blind, Double-Dummy, Five-Way Crossover Clinical Trial of Single Doses of Salmeterol 25, 50, and 100mcg Via Diskus (Multidose Powder Inhaler), Salmeterol 50mcg Via Metered-Dose Inhaler and Placebo in Adolescent and Adult Subjects With Moderate Asthma.
SLGA3009 Completed A 12-month, open-label trial to assess the long-term safety of salmeterol 50 mg bid via the DISKUS in adolescent and adult patients with asthma.
SLGA3010 Completed A randomized, double-blind, double-dummy, comparative clinical trial of salmeterol 50mcg via the Diskus and salmeterol 50mcg via the metered-dose inhaler versus placebo for 12 weeks in adolescent and adult subjects with mild-to-moderate asthma.
SLGA3011 Completed A randomized, double-blind, double-dummy, comparative clinical trial of salmeterol 50mcg via the Diskus and salmeterol 50mcg via the metered-dose inhaler versus placebo for twelve weeks in adolescent and adult subjects with mild-to-moderate asthma.
SLGA4004 Completed A Randomized, Double-blind, Double-Dummy, Comparative Clinical Trial of 12-Week Courses of Salmeterol Xinafoate Versus Ipratropium Bromide Versus Placebo (PRN Ventolin) in Subjects With Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
SLGA4005 Completed A Randomized, Double-Blind, Double-Dummy, Comparative Clinical Trial of 12-Week Courses of Salmeterol Xinafoate Versus Ipratropium Bromide Versus Placebo (PRN Ventolin®) in Subjects With Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
SLGA4020 Completed A Comparison of Salmeterol Versus Theophylline Versus Salmeterol Plus Theophylline in COPD Patients
SLGA4021 Completed A Comparison of Salmeterol Versus Theophylline Versus Salmeterol Plus Theophylline in COPD Patients
SLGA5011 Completed SMART: A Double-Blind, Randomized, Placebo-Controlled Surveillance Study of Asthma Event Outcomes in Subjects Receiving Either Usual Pharmacotherapy of Asthma or Usual Pharmacotherapy Plus Salmeterol 42mcg Twice Daily Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.